Jnana Therapeutics
Business Services · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
6 Tide St, Boston, Massachusetts, 02210,...Website
www.jnanatx.comRevenue
$23.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Jnana Therapeutics
Jnana Therapeutics is focused on leveraging chemoproteomics to accelerate the discovery of new small molecules aimed at transforming disease treatment. Their RAPID platform enables the systematic development of small molecule medicines with exceptional speed and efficiency, targeting conditions such as phenylketonuria (PKU) and various immune-mediated diseases. The company is dedicated to unlocking high-value therapeutic targets that have been previously inaccessible, thereby enhancing drug discovery processes. Jnana Therapeutics seeks partnerships and collaboration to further advance their innovative drug discovery initiatives.Explore more
Jnana Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Jnana Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Jnana Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Jnana Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Jnana Therapeutics has new funding data
Product Launch: Get notified when Jnana Therapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at Jnana Therapeutics
Check if Jnana Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Click to see if Jnana Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Jnana Therapeutics recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Jnana Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Jnana Therapeutics
Compare insights from companies similar to Jnana Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Jnana Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Jnana Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Jnana Therapeutics.
Jnana Therapeutics financials insights
Gather financial insights about Jnana Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Series A
$50M
2021
Series B
$50M
2022
Series C
$107M
Jnana Therapeutics Tech Stack
A closer look at the technologies used by Jnana Therapeutics
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Jnana Therapeutics News & Media
Otsuka pays $800M for Jnana and its clinical-stage PKU drug - Fierce Biotech
Otsuka Pharmaceutical has picked up Boston-based Jnana | Otsuka Pharmaceutical has picked up Boston-based Jnana Therapeutics for $800 million so the Japanese biotech can get its hands on a clinical-stage oral phenylketonuria drug.Otsuka Pharmaceutical to Acquire Jnana Therapeutics Inc.
Otsuka Pharmaceutical to acquire Jnana Therapeutics Inc.Jnana Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
Jnana CEO Joanne Kotz will present a corporate overview at the RBC Capital Markets Global Healthcare Conference on Tuesday, May 14, 2024 at 2:05 p.m. ET.Phenylketonuria Market to Exhibit Significant Growth, Assesses DelveInsight | Key Companies - BioMarin, Synlogic, PTC Therapeutics, Jnana Therapeutics, Homology Medicines
The phenylketonuria market is expected to grow in 7MM in the coming years due to factors like an increase in the patient pool and the expected entry of emerging therapies by leading pharma and biotech companies. The phenylketonuria market is expected to grow in 7MM in the coming years due to factors like an increase in the patient pool and the expected entry of emerging therapies by leading pharma and biotech companies.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Jnana Therapeutics
Sign Up For FreeTo access detailed company insights
Jnana Therapeutics is focused on leveraging chemoproteomics to accelerate the discovery of new small molecules aimed at transforming disease treatment. Their RAPID platform enables the systematic development of small molecule medicines with exceptional speed and efficiency, targeting conditions such as phenylketonuria (PKU) and various immune-media... Read More
